Physician profile
Timothy P Murphy
NPI 1427023886
$570.44
in general payments reported to CMS, 2019-2025
18 companies · $81.74 in 2025
The $81.74 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $80.09 · 2022: $81.20 · 2023: $98.61 · 2024: $50.56 · 2025: $81.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $100.77 | 2019-2025 | |
| Shire North American Group INC | $56.57 | 2019 | |
| Supernus Pharmaceuticals, INC. | $48.54 | 2019-2022 | |
| Astellas Pharma US INC | $42.49 | 2019-2023 | Myrbetriq |
| Novo Nordisk INC | $40.88 | 2019-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $40.10 | 2022-2024 | Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $32.99 | 2025 | Gemtesa |
| Abbvie INC. | $32.70 | 2023 | |
| Glaxosmithkline, LLC. | $24.24 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.12 | 2022 | |
| Allergan, INC. | $21.60 | 2020 | |
| Jazz Pharmaceuticals INC. | $20.88 | 2020 | |
| Amgen INC. | $16.95 | 2023 | Evenity, Prolia |
| Novartis Pharmaceuticals Corporation | $16.81 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.19 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $13.87 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.08 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.